Tag | Content |
---|
EnhancerAtlas ID | HS091-20905 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr17:67264200-67266720 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
CEBPA | MA0102.3 | chr17:67265481-67265492 | TATTATGCAAT | - | 6.02 | IRF1 | MA0050.2 | chr17:67264433-67264454 | TTTTACTTTCATTTTCCTGTC | + | 7.25 | IRF2 | MA0051.1 | chr17:67264432-67264450 | ATTTTACTTTCATTTTCC | - | 6.97 | NFAT5 | MA0606.1 | chr17:67265590-67265600 | AATGGAAAAT | - | 6.02 | NFATC1 | MA0624.1 | chr17:67265590-67265600 | AATGGAAAAT | - | 6.02 | NFATC3 | MA0625.1 | chr17:67265590-67265600 | AATGGAAAAT | - | 6.02 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_68154 | chr17:67263945-67324362 | TC32 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr17 | 67264765 | 67264941 | chr17 | 67265161 | 67265439 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH17I069268 | chr17 | 67264311 | 67266321 |
|
Enhancer Sequence | AAAGACAACC ACAGAGTAAC AAATGGAACT GAGAATCATT TTATATCTTA AGATATATCT 60 TAGGATATAT CTTATATCAA AAAAAAATCA AAACCTCAGA AAGAATGTAT TAGAATATCT 120 AACCCAGGCA TAGTCTACAT GAAAGAATGA GTGGCAGATG TATTAACAGG TGGTTGTGGA 180 CAATATTACC AACTCTGCCA CTTATTAATA ACTATCTGAT CCTAAGCAAA TCATTTTACT 240 TTCATTTTCC TGTCTACAAC ACAGAATAAT CAGGCATATA AATTACGCTT CACAATTTCA 300 TAAAAATGAA TGATGTATTT GAAAAGCAGT TAGTATGTCC ACCATAGTGG TCCTATGAAA 360 TAATAATAAA TATCTAAGAA TGATATTTGT TGCTCTTGTC TTTTTAATTG GGAAAAGCTA 420 TATCCAAGCT CAGCTTCCTA TGGAACTAGA ACTTCTTCTC CCAAGCAGAA GAGGAATTAA 480 CTCCCACAGG CCCCAATGTC GTTAGCTTCC CCAGGGATCC AGGTGCAGTC AGCTAACTTT 540 CCCAGACAAT CAATAAACAG CTAGCACTTC AAATGCAGAT TACCCAAGTC CAAGGATACT 600 ATATTATCAG CCACCCTCAC CAAGGTCAGT TTCCTCCCCT TGTTCTATAA GAATACAGAC 660 CCGTGGGACA GAGAAGGTAC TCTGCACTGG AATAGAATCC GCAGTGCCTA GCAGATACCC 720 TCGCACTGGC ACACCCCTCC ATGGGATGAC ATAGAGACAG AGTACATCAC TGTCTTGCTG 780 AAACCTAGCC TTCTGAGTTT TCCTATTTAG CAATTAAGTC AATTCCAAAG TTCAGGTCAT 840 ATGACATTGC AGAATTTGTC TGAAACTCTC GTAATATGAC AGTGGAGGCT CAGAAAGAAC 900 CCACAAATAT GTAGACTAGT AGTGCAAGAA GTGGAAATGA ATGAGACTAC AGTTGGATCC 960 AATCATACAG AATCTAATGA AGAAACAAAT TTGAAATATT AATACGACTA TATATGAATA 1020 GTTAGCTTCA AAAACTCCCA TGTATTTCTT TCGAAATATA GTATGATTAT ATGTCAGTGT 1080 TGTTGAAAAT TGTAAGTTGT AAAATCTTGT GTAATAGTTA TGGATACAGA CATATGTAGT 1140 AACATCAAAA AAACACGTAT GGGAATTACA AATTGTGAAA TTGTGAATTG CGGTTACTCC 1200 TACGGAGGAG AGAAGGAAAC AAGATTGGAG AGGGGTAACA TGAGTTTTCA CCTGTGTCTT 1260 AAAAGTTTTA CTAAAAACAA ATATTATGCA ATATTAACAT TTGAAATATT TGGATAGTAG 1320 GTGGTTCGTT TTCTGTACGT TTGAAATATT TCATAATATG AGATACCTCT CCACAGACAC 1380 TGCTGCTGGA AATGGAAAAT GATGCAACCA TTTTGGAAAG CAGTTTGGCA GTTCTTCAAG 1440 TGTTAAACAT AGAGTTACTA GATGATCTAG CAATTCCACT CCTAATTATA TATCCAAGAG 1500 AAATAAAAAC ATATGCTCAT ACAAAATCTT CTACTCAAAT ATTCATAAGC ATTACTCATA 1560 ATAGCCAAAA GGTGGAAATA ACCCAAATGC CATCAACTGA TGAACAGATA AGTAGAATGC 1620 AGTATTTCAC ATAAACATTC CATACATTCC ACACAATGAA ATATGATTTG GTAGTAAAAA 1680 TAAATGAAGC ACTGATACGT GTTACAAAAC AGATGAATCT TCAAAGCAGT ATGCTAAGTA 1740 CAAGAAAGCA GACAAAAAAG ACTACATACT GTATGATTCC ATTTATATAA AATGTCTAAA 1800 ATAAGGAAAT CCATAGAAAC AGAAAGTACA TTAGTGGTTG CCTAGGGTTG GGAGTGGGTA 1860 TGAGAGGAAA TGAGTGATTA CTAATGAGTA TAAGGGTTAT TTTTTTTGGA GGGGGGTGAT 1920 GGCATATTTA AAACTGACTG TAGTGATGAC TGCACAACTC TATAAGCATA ATAAAAGACA 1980 CCGAAGTGTA TACTTTGAAT AATGGTCAGG TTGATTGGGC ATTATATTTC AATGAAGCTG 2040 TTTTTAAAAG TATGAAAAGA AGAAGATAGA AAATATTGTT ACAGATATTT GTCCATTTAT 2100 TTTTTAGCAT ATGAAAATCA AAAGGATTAA GAGAAAATAT GTTGGATACT TTTCTGTAAT 2160 CTTGATTCTG ATATGTACAA TCCAACAGTT CTATCTAGAG GAAAAATGGT TGCCTGGGTG 2220 ACTTCTCAAG TTTTTTTCAA TACCCAATAC CTGGATTTTA GGTAAAAAAT ATTCATTTAA 2280 AAATTATCTT ATATTTTATT CTATGATCAA TATAGAACAC ACTTATTCCT TATACAAATA 2340 TTAATACCAA AACAGAATCT CCTTTACCCT GAAACATACT TCTACTGGGG AATCCTAAAC 2400 CTTAATGTAA ACCGTTTCTC ACTTGAGTTT TAAGAAGTCT AAGAGATCTC ACAAGATAAA 2460 TTTCTACATA TTTTGTTATT TTTGCTTAGT TTTTAATGGT TATTATATAT ATGACATGCA 2520
|